Japanese guidelines for dimethyl fumarate
Japanese guidelines for dimethyl fumarate is a scholarly work, published in 2018 in ''Clinical & experimental neuroimmunology''. The main subjects of the publication include medicine, guideline, rheumatoid arthritis, multiple sclerosis, clinical trial, neuromyelitis optica, placebo, dimethyl fumarate, internal medicine, glatiramer acetate, and adverse effect. Consequently, in December 2016,DMFwas approved as the second oral disease‐modifying drug forMSin Japan.